These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25029852)

  • 41. [miR-378 suppresses HBV-related hepatocellular carcinoma tumor growth by directly targeting the insulin-like growth factor 1 receptor].
    Li LH; Gao Q; Wang XY; Guo ZJ
    Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):609-13. PubMed ID: 24119742
    [TBL] [Abstract][Full Text] [Related]  

  • 42. miR-19a promotes the metastasis and EMT through CUL5 in prostate cancer cell line PC3.
    Wang Y; Hu J; Qi G; Wang S; Gao J
    J BUON; 2020; 25(4):2028-2035. PubMed ID: 33099949
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.
    Fujita Y; Kojima K; Hamada N; Ohhashi R; Akao Y; Nozawa Y; Deguchi T; Ito M
    Biochem Biophys Res Commun; 2008 Dec; 377(1):114-9. PubMed ID: 18834855
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells.
    Li Z; Hu S; Wang J; Cai J; Xiao L; Yu L; Wang Z
    Gynecol Oncol; 2010 Oct; 119(1):125-30. PubMed ID: 20624637
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IGF-1-mediated PKM2/β-catenin/miR-152 regulatory circuit in breast cancer.
    Wen YY; Liu WT; Sun HR; Ge X; Shi ZM; Wang M; Li W; Zhang JY; Liu LZ; Jiang BH
    Sci Rep; 2017 Nov; 7(1):15897. PubMed ID: 29162853
    [TBL] [Abstract][Full Text] [Related]  

  • 46. microRNA-330 inhibits cell motility by downregulating Sp1 in prostate cancer cells.
    Mao Y; Chen H; Lin Y; Xu X; Hu Z; Zhu Y; Wu J; Xu X; Zheng X; Xie L
    Oncol Rep; 2013 Jul; 30(1):327-33. PubMed ID: 23670210
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [miR-497 suppresses proliferation of human cervical carcinoma HeLa cells by targeting cyclin E1].
    Han J; Huo M; Mu M; Liu J; Zhang J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):597-600. PubMed ID: 24909281
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cells.
    Wu H; Li Z; Yang P; Zhang L; Fan Y; Li Z
    Cell Signal; 2014 Nov; 26(11):2397-405. PubMed ID: 25041845
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Knockdown of PKM2 induces apoptosis and autophagy in human A549 alveolar adenocarcinoma cells.
    Chu B; Wang J; Wang Y; Yang G
    Mol Med Rep; 2015 Sep; 12(3):4358-4363. PubMed ID: 26082202
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNA-181b expression in prostate cancer tissues and its influence on the biological behavior of the prostate cancer cell line PC-3.
    He L; Yao H; Fan LH; Liu L; Qiu S; Li X; Gao JP; Hao CQ
    Genet Mol Res; 2013 Apr; 12(2):1012-21. PubMed ID: 23613247
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Knockdown of PKM2 Suppresses Tumor Growth and Invasion in Lung Adenocarcinoma.
    Sun H; Zhu A; Zhang L; Zhang J; Zhong Z; Wang F
    Int J Mol Sci; 2015 Oct; 16(10):24574-87. PubMed ID: 26501265
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MiR-34a affects G2 arrest in prostate cancer PC3 cells via Wnt pathway and inhibits cell growth and migration.
    Dong B; Xu GC; Liu ST; Liu T; Geng B
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8349-8358. PubMed ID: 32894541
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Down-Regulation of Nfatc1 Suppresses Proliferation, Migration, Invasion, and Warburg Effect in Prostate Cancer Cells.
    Liu Y; Liang T; Qiu X; Ye X; Li Z; Tian B; Yan D
    Med Sci Monit; 2019 Feb; 25():1572-1581. PubMed ID: 30817743
    [TBL] [Abstract][Full Text] [Related]  

  • 54. LincRNA-p21 suppresses development of human prostate cancer through inhibition of PKM2.
    Wang X; Xu Y; Wang X; Jiang C; Han S; Dong K; Shen M; Xu D
    Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28994148
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prostate androgen-regulated gene: a novel potential target for androgen-independent prostate cancer therapy.
    Xu XF; Zhou SW; Zhang X; Ye ZQ; Zhang JH; Ma X; Zheng T; Li HZ
    Asian J Androl; 2006 Jul; 8(4):455-62. PubMed ID: 16763722
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of Nkx3.1 enhances 17beta-estradiol anti-tumor action in PC3 human prostate cancer cells.
    Wang P; Liu B; Luo JD; Zhang ZG; Ma Q; Chen ZD
    Asian J Androl; 2007 May; 9(3):353-60. PubMed ID: 17486276
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression of microRNA-122 re-sensitizes 5-FU-resistant colon cancer cells to 5-FU through the inhibition of PKM2 in vitro and in vivo.
    He J; Xie G; Tong J; Peng Y; Huang H; Li J; Wang N; Liang H
    Cell Biochem Biophys; 2014 Nov; 70(2):1343-50. PubMed ID: 24898807
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Downregulation of Id1 by small interfering RNA in prostate cancer PC3 cells in vivo and in vitro.
    Ling YX; Tao J; Fang SF; Hui Z; Fang QR
    Eur J Cancer Prev; 2011 Jan; 20(1):9-17. PubMed ID: 20881502
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of small interfering RNA targeting hypoxia-inducible factor-1α on radiosensitivity of PC3 cell line.
    Huang Y; Yu J; Yan C; Hou J; Pu J; Zhang G; Fu Z; Wang X
    Urology; 2012 Mar; 79(3):744.e17-24. PubMed ID: 22196409
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PKM2 contributes to cancer metabolism.
    Wong N; Ojo D; Yan J; Tang D
    Cancer Lett; 2015 Jan; 356(2 Pt A):184-91. PubMed ID: 24508027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.